These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34745998)

  • 1. The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer.
    Li J; Yu N; Li X; Cui M; Guo Q
    Front Oncol; 2021; 11():759894. PubMed ID: 34745998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Sequencing in Genitourinary Malignancies.
    Murphy N; Shah P; Shih A; Khalili H; Liew A; Zhu X; Lee A
    Adv Exp Med Biol; 2020; 1255():153-164. PubMed ID: 32949398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor heterogeneity: A new perspective on colorectal cancer research.
    Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
    Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Resistance in Cancers: A Free Pass for Bullying.
    Li J; Li X; Guo Q
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities.
    Kalasekar SM; VanSant-Webb CH; Evason KJ
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor evolution and chemoresistance in ovarian cancer.
    Kim S; Han Y; Kim SI; Kim HS; Kim SJ; Song YS
    NPJ Precis Oncol; 2018; 2():20. PubMed ID: 30246154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach.
    Goto T; Hirotsu Y; Amemiya K; Mochizuki H; Omata M
    Cancers (Basel); 2018 Jun; 10(7):. PubMed ID: 29932159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies.
    Mishra R
    Pathol Res Pract; 2024 Jan; 253():154953. PubMed ID: 38039738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
    Kim M; Lee S; Lim S; Kim S
    PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.
    Ellsworth DL; Blackburn HL; Shriver CD; Rabizadeh S; Soon-Shiong P; Ellsworth RE
    Clin Transl Med; 2017 Dec; 6(1):15. PubMed ID: 28405930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.
    Kikutake C; Yoshihara M; Sato T; Saito D; Suyama M
    Oncotarget; 2018 Dec; 9(102):37689-37699. PubMed ID: 30701024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
    Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
    Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic heterogeneity in cancer.
    Guo M; Peng Y; Gao A; Du C; Herman JG
    Biomark Res; 2019; 7():23. PubMed ID: 31695915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
    Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
    Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
    Brychtová V; Valík V; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
    Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
    Mol Cancer; 2019 Jan; 18(1):7. PubMed ID: 30626401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling.
    Niida A; Nagayama S; Miyano S; Mimori K
    Cancer Sci; 2018 Apr; 109(4):884-892. PubMed ID: 29352488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma.
    Lopez JI; Cortes JM
    F1000Res; 2016; 5():385. PubMed ID: 27127618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
    Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
    Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.